Veterinary

 

 

With the animal vaccines market predicted to be worth $8.6 billion by 2018, can you really afford not to be a core service provider for these manufacturers? An increased focus on zoonotic infectious diseases and more attention towards the economic impact of disease in livestock of economic importance, make it clear why veterinary vaccines are coming into the limelight. This event will provide a platform for you to showcase how you are moving veterinary vaccine development methods forward, from technology to regulation and manufacture.

 

 

Who Attends

 

• Pharma
• Biotech
• National and International Government
• Academics And Research Institutions

 

Job Titles

 

• CEO / CSO / COO
• CMO / Head of Scientific Affairs
• Head of Poultry / Avian / Bovine/ Swine/ Livestock
• Head of Infectious Disease
• Head of R&D
• Head of Manufacturing

Who Should Sponsor?

 

• CMOs
• OEMs / Equipment Manufacturers
• Platform Technology Providers
• Biotechs
• Big Pharma

 

Veterinary Vaccines Conference, Tuesday 16 April 2019

Scientific Advancements in Animal Health

Simon Graham
Veterinary Vaccines Conference
09:10

Structural vaccinology and its potential impact on the next generation of veterinary vaccines

10:40

Networking Coffee Break

Thomas Monath
Veterinary Vaccines Conference
11:40

Animal viruses engineered as human vaccines against infections of animals transmissible to humans

Channing Sebo
Veterinary Vaccines Conference
12:10

Incorporating precision vaccines into swine health: The use of RNA tech Sequivity to develop custom vaccines targeting specific diseases in individual herds

Dr Adel Talaat
Veterinary Vaccines Conference
12:40

Nanovaccines and nano-adjuvants for efficient vaccination programs

13:10

Networking Lunch & Poster Session

Precision Medicine Approaches for Animal Health

Tad Sonstegard
Veterinary Vaccines Conference
14:40

Precision breeding for animal health: How gene editing will improve our livestock systems

Andy Hillier
Veterinary Vaccines Conference
15:10

Monoclonal antibodies for companion animal allergic skin diseases

Peter Nara
Veterinary Vaccines Conference
15:40

Deceptive imprinting: A cosmopolitan host immune evading strategy of animal health pathogens

16:09

Networking Coffee Break

Vaccine Delivery & Manufacture

Dr Dale Polson
Veterinary Vaccines Conference
16:40

Where is the future in veterinary vaccine delivery?

Heather Bessoff
Veterinary Vaccines Conference
17:10

Mucosal PRRSV vaccine for swine

  • Benefits of administration via nasal spray
  • Vaccine efficacy
  • Summary of field trial data and findings
Session led by: aptimmune-biologics-inc
Lisa Bielke
Veterinary Vaccines Conference
17:40

Orally administered vaccines for poultry

18:10

Chair’s Closing Remarks per co-lo and Close of Congress Day 2

18:15

Off-site Networking Drinks, Supported by Enesi Pharma

last published: 18/Mar/19 16:25

Veterinary Vaccines Conference, Wednesday 17 April 2019

Alternatives to Antibiotics

Dr Robert Nordgren
Veterinary Vaccines Conference
09:40

Developing vaccines against bacterial pathogens in animal species and humans using a salmonella vaccine vector platform

Cindy Burnsteel
Veterinary Vaccines Conference
10:10

Regulatory pathways to enable the licensing of alternatives to antibiotics

10:40

Networking Coffee Break

Emerging & Re-Emerging Diseases

Lisa Conti
Veterinary Vaccines Conference
11:30

Establishing a One Health approach to combat emerging zoonotic & transboundary diseases

Jonna Mazet
Veterinary Vaccines Conference
11:45

PREDICT project: Detection and discovery of zoonotic diseases at the wildlife-human interface

Douglas Gladue
Veterinary Vaccines Conference
12:15

African Swine Fever – Still no vaccine, updates on how the animal health industry is targeting this disease?

12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Paul Offit
13:40

New lessons from old controversies

  • What have we learnt from previous vaccines failures to drive new vaccines forward?
  • Why is there is low uptake on currently available vaccines? E.g. HPV & influenza
  • Examples and case studies from: Lyme & Rota – what does this mean for future vaccine innovation and R&D?
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 18/Mar/19 16:25

ONE HEALTH, Monday 15 April 2019

MORNING PLENARIES RENAISSANCE BALLROOM

Gregory Poland
08:20

Chair’s opening remarks

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic
Brett Giroir
08:30

Strengthening the effectiveness of national, state & local efforts to improve the uptake of HPV vaccination

Panel discussion
08:45

Plenary keynote insights: What direction will vaccines take to ensure safety and mass immunization

  • Vaccine Research and Development in the Public Sector
  • What kind of regulatory and political support can we expect?
  • Prevention and pre-prepared efforts to ensure our current and future safety
  • Vaccine development and innovation including the current landscape, existing challenges, and drivers and levers to incentivize development
Panel discussion
10:45

Networking Coffee Break

INTERACTIVE ROUNDTABLES

11:45

Artificial intelligence -adopting cognitive computing across the PV landscape

11:45

Changing landscape of real-world evidence and its impact on clinical research – uncovering lab & clinical adverse events

Dr James Cummings
11:45

Developing more effective vaccines for emerging/re-emerging pandemic threats

Dr James F. Cummings, MD, President, ICON Government and Public Health Solutions – title TBC
11:45

Development of novel predictive algorithms for patient selection

Jason Berg
11:45

Identifying the ideal vaccine research site – lessons learned from the field

Senior representative, PPD
Dr Richard Kennedy
11:45

Immune Profiling - capturing the complexity of immune responses to vaccines and infections

Dr Michael Salgaller
11:45

Oncology – applying precision medicine and informatics to find the best treatment option for each patient

11:45

Overcoming obstacles to improve cold chain management of biologics

11:45

Pediatric Vaccine Trials – Recruitment and Retention

Dr Nathalie Garcon
11:45

Safety evaluation of vaccines: from now to tomorrow, new approaches and technologies?

Dr Nathalie Garcon, CSO & CEO, Bioaster
Cynthia Dukes
11:45

Seasonal vaccine studies: Critical success factors

Cynthia Dukes, VP, Scientific and Clinical Services and Head of Vaccine Center of Excellence, ICON Clinical Research – title TBC
Dr Jun Tang
11:45

When limited patient resources meet unlimited immunotherapy combinations—the strategies to develop clinical IO agents in platform studies

13:10

Networking Lunch (Exhibition Hall)

AFTERNOON PLENARIES

Panel discussion
14:40

The role of vaccines to combat antibiotic-microbial resistance

  • What can we do to manage AMR? The mis-use of Abx in bacterial and viral infections
  • How vaccine regulatory and access policies can be used to strengthen utilization of vaccines as a component of multi-pronged strategies that governments should take in their national action plans to address AMR
  • The need for a holistic and collaborative strategy including cross species considerations
Panel discussion
16:30

Networking Coffee Break

ONE HEALTH

Panel discussion
Panel discussion
ONE HEALTH
17:50

Operational framework for strengthening human & animal public health systems at their interface

  • What tools and resources from the human health, animal health, and disaster risk reduction sectors can facilitate multi-sectoral coordination?
  • Strategy for appropriate One Health entry points and a pathway to the prevent-detect-respond-recover spectrum of preparedness
  • What public health system changes do we need to truly facilitate a One Health approach?
18:40

Chair’s Closing Remarks and Close of Congress Day 1

18:50

Pre-Awards Networking Drinks Reception (off-site)

19:30

Gala Dinner & 12th Annual ViE Awards Ceremony

last published: 18/Mar/19 16:25

 

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071